Profile data is unavailable for this security.
About the company
Fuso Pharmaceutical Industries Ltd is a Japan-based company principally engaged in the manufacture and sale of pharmaceuticals and medical equipment. The pharmaceuticals business involves the manufacture and sale of pharmaceuticals and medical equipment, including injectables centered on infusion solutions and dialysis agents for artificial kidneys, as well as contract manufacturing of pharmaceuticals. The real estate business involves the leasing of real estate.
- Revenue in JPY (TTM)62.17bn
- Net income in JPY-4.01bn
- Incorporated1937
- Employees1.34k
- LocationFuso Pharmaceutical Industries Ltd1-7-10, Dosho-machi, Chuo-kuOSAKA-SHI 541-0045JapanJPN
- Phone+81 662035671
- Fax+81 662316886
- Websitehttps://www.fuso-pharm.co.jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stella Pharma Corp | 968.76m | -279.32m | 12.66bn | 43.00 | -- | 4.70 | -- | 13.07 | -8.21 | -8.21 | 28.47 | 79.22 | 0.1966 | 0.0944 | 2.91 | 22,529,260.00 | -5.67 | -16.41 | -5.96 | -18.19 | 87.88 | 87.03 | -28.83 | -176.16 | 13.81 | -45.69 | 0.226 | -- | 256.62 | -- | 81.56 | -- | -21.34 | -- |
| CellSeed Inc | 83.68m | -1.10bn | 13.31bn | 38.00 | -- | 10.09 | -- | 159.04 | -31.83 | -31.83 | 2.41 | 35.67 | 0.0409 | 0.6561 | 3.81 | -- | -54.00 | -46.88 | -59.08 | -50.95 | 51.09 | 53.64 | -1,319.46 | -593.85 | 5.81 | -- | 0.0949 | -- | -56.71 | -15.95 | -28.41 | -- | 21.04 | -- |
| Immuno-Biological Laboratories Co., Ltd. | 1.03bn | 363.89m | 15.14bn | 58.00 | 41.59 | 8.59 | 39.59 | 14.67 | 39.07 | 39.07 | 110.76 | 189.25 | 0.5456 | 0.8603 | 4.81 | 17,786,030.00 | 19.25 | -4.96 | 22.46 | -5.77 | 70.35 | 62.70 | 35.27 | -11.27 | 3.96 | 2,702.08 | 0.0947 | -- | 18.71 | 10.95 | 33.40 | -- | -- | -- |
| ReproCell Inc | 2.52bn | -324.61m | 15.45bn | 99.00 | -- | 1.76 | -- | 6.13 | -3.42 | -3.42 | 26.63 | 92.82 | 0.2328 | 4.15 | 5.92 | 25,450,770.00 | -3.00 | -4.09 | -3.63 | -4.47 | 49.35 | 43.75 | -12.88 | -13.66 | 4.93 | -- | 0.00 | -- | 22.74 | 19.94 | 428.65 | -- | -6.31 | -- |
| TAIKO PHARMACEUTICAL CO LTD | 6.40bn | 923.00m | 15.60bn | 214.00 | 16.76 | 1.82 | 13.12 | 2.44 | 18.37 | 18.37 | 127.34 | 169.51 | 0.5080 | 1.77 | 2.62 | -- | 7.34 | -18.99 | 9.32 | -24.04 | 54.42 | 40.20 | 14.44 | -46.31 | 2.72 | -- | 0.0874 | -- | 1.67 | -- | 2.78 | -- | -- | -- |
| CanBas Co Ltd (Parent) | 0.00 | -1.25bn | 17.39bn | 14.00 | -- | 7.31 | -- | -- | -64.11 | -64.11 | 0.00 | 120.62 | 0.00 | -- | -- | 0.00 | -44.48 | -57.04 | -46.19 | -62.13 | -- | -- | -- | -4,587.85 | -- | -566.18 | 0.00 | -- | -- | -- | 4.27 | -- | -- | -- |
| StemRIM Inc | 0.00 | -1.90bn | 18.62bn | 45.00 | -- | 2.71 | -- | -- | -30.56 | -30.56 | 0.00 | 109.73 | 0.00 | -- | -- | 0.00 | -24.08 | -12.71 | -24.55 | -12.88 | -- | -- | -- | -167.35 | 47.00 | -- | 0.00 | -- | -- | -- | 4.59 | -- | -22.11 | -- |
| Ohki Healthcare Holdings Co Ltd | 359.41bn | 2.43bn | 19.01bn | 648.00 | 7.57 | 0.5546 | 6.72 | 0.0529 | 178.43 | 178.43 | 26,346.69 | 2,435.83 | 2.26 | 9.83 | 4.34 | 554,637,400.00 | 1.53 | 1.77 | 6.23 | 7.74 | 5.31 | 5.26 | 0.677 | 0.6977 | 0.8306 | -- | 0.2686 | 14.17 | 4.42 | 4.74 | 19.41 | 2.21 | 45.68 | 6.47 |
| Astena Holdings Co Ltd | 62.74bn | 2.19bn | 19.97bn | 1.42k | 8.96 | 0.7239 | 4.34 | 0.3183 | 54.22 | 54.22 | 1,555.72 | 671.41 | 0.8961 | 3.62 | 2.88 | -- | 3.11 | 0.9587 | 6.26 | 1.76 | 34.85 | 30.40 | 3.47 | 1.05 | 0.9228 | -- | 0.4519 | 114.25 | 8.19 | -0.808 | 186.60 | 1.97 | 12.61 | 2.38 |
| Kubota Pharmaceutical Holdings Co Ltd | 21.34m | -676.25m | 20.31bn | 19.00 | -- | 11.20 | -- | 952.01 | -10.91 | -10.91 | 0.3341 | 15.72 | 0.0121 | 3.54 | 7.98 | -- | -38.41 | -44.81 | -42.10 | -49.35 | -14.68 | -- | -3,169.69 | -8,411.59 | 12.49 | -- | 0.0121 | -- | -21.53 | -10.80 | 49.26 | -- | -4.55 | -- |
| Fuso Pharmaceutical Industries Ltd | 62.17bn | -4.01bn | 22.43bn | 1.34k | -- | 0.5846 | -- | 0.3608 | -469.00 | -469.00 | 7,280.21 | 4,059.08 | 0.7307 | 3.25 | 2.32 | 46,394,780.00 | -4.71 | 0.7682 | -9.76 | 1.29 | 26.39 | 26.94 | -6.44 | 1.05 | 0.8228 | 69.88 | 0.4617 | 106.29 | 9.31 | 5.25 | -338.78 | -- | 4.37 | 6.45 |
| Renascience Inc | 106.94m | -258.99m | 24.18bn | 3.00 | -- | 9.81 | -- | 226.11 | -20.35 | -20.35 | 8.40 | 186.09 | 0.0479 | -- | 4.86 | 35,648,000.00 | -11.59 | -8.97 | -12.40 | -9.35 | 95.94 | 84.44 | -242.17 | -107.53 | -- | -- | 0.00 | -- | -31.66 | 13.00 | 143.91 | -- | -- | -- |
| RaQualia Pharma Inc | 3.98bn | 273.12m | 28.67bn | 85.00 | 122.90 | 3.91 | 37.66 | 7.20 | 8.97 | 8.97 | 165.54 | 281.96 | 0.3947 | 4.35 | 3.04 | -- | 2.71 | 2.64 | 3.08 | 2.90 | 82.11 | 85.46 | 6.86 | 6.36 | 4.33 | 6.63 | 0.2962 | -- | 28.07 | 29.16 | 155.17 | -- | -13.74 | -- |
Data as of Feb 17 2026. Currency figures normalised to Fuso Pharmaceutical Industries Ltd's reporting currency: Japanese Yen JPY
9.12%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Nomura Asset Management Co., Ltd.as of 05 Feb 2026 | 264.30k | 2.80% |
| Sumitomo Mitsui Trust Asset Management Co., Ltd.as of 30 Jan 2026 | 138.40k | 1.46% |
| Dimensional Fund Advisors LPas of 05 Feb 2026 | 116.54k | 1.23% |
| Amova Asset Management Co., Ltd.as of 30 Jan 2026 | 113.10k | 1.20% |
| Daiwa Asset Management Co. Ltd.as of 30 Jan 2026 | 107.60k | 1.14% |
| Mitsubishi UFJ Asset Management Co., Ltd.as of 05 Feb 2026 | 49.80k | 0.53% |
| Norges Bank Investment Managementas of 30 Jun 2025 | 23.60k | 0.25% |
| BlackRock Japan Co. Ltd.as of 05 Feb 2026 | 19.20k | 0.20% |
| Mellon Investments Corp.as of 06 Feb 2026 | 17.00k | 0.18% |
| Asset Management One Co., Ltd.as of 05 Feb 2026 | 12.10k | 0.13% |
More ▼
Data from 31 Dec 2025 - 12 Feb 2026Source: FactSet Research Systems Inc.
